Plus Therapeutics | CYTX - Cash And Equivalent


Plus Therapeutics reported $8.55M in Cash and Equivalent for its fiscal quarter ending in December of 2023.





Cash And Equivalent Change Date
Baxter International USD 1.97B 240M Dec/2025
Cerus USD 15.67M 321K Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Haemonetics USD 363.37M 66.94M Dec/2025
Infinity Pharmaceuticals USD 17.75M 7.99M Jun/2023
Northwest Biotherapeutics USD 4.56M 244K Sep/2025
Plus Therapeutics USD 8.55M 2.45M Dec/2023
Sanofi EUR 7.66B 1.25B Dec/2025
Starpharma Holdings AUD 15.41M 4.87M Jun/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025